Microbiome in antibiotic-associated diarrhea

Normal Gut Flora - The Body's Inner Ecosystem

• Composition: A dense, diverse community of primarily anaerobic bacteria (Bacteroides, Firmicutes) that create a barrier against pathogens.
• Key Functions:
  • Metabolic: Synthesizes Vitamin K, biotin; ferments complex carbs into Short-Chain Fatty Acids (SCFAs) like butyrate (colonocyte fuel).
  • Protective: Prevents pathogen colonization through competition for space and nutrients.
  • Immunologic: Modulates development of Gut-Associated Lymphoid Tissue (GALT).

⭐ Broad-spectrum antibiotics like Clindamycin, Ampicillin, and Cephalosporins are most frequently implicated in causing pseudomembranous colitis.

Pathophysiology - When Antibiotics Attack

• Antibiotic Action: Broad-spectrum antibiotics (e.g., clindamycin, cephalosporins, fluoroquinolones) eradicate susceptible gut commensals.
• Dysbiosis: This disrupts the normal microbiome, reducing metabolic competition and protective bacteriocins.
  • Leads to ↓ loss of colonization resistance.
  • Allows antibiotic-resistant organisms like Clostridioides difficile to proliferate from a spore state.
• C. difficile Pathogenesis:
  • Vegetative cells produce exotoxins.
    • Toxin A (enterotoxin): Causes inflammation and fluid secretion.
    • Toxin B (cytotoxin): More potent; disrupts cytoskeleton leading to cell death.
  • Toxins cause mucosal injury, neutrophil infiltration, and formation of characteristic pseudomembranes.

⭐ C. difficile toxins glucosylate and inactivate Rho family GTPases, leading to actin cytoskeleton disruption, epithelial cell death, and loss of intestinal barrier function.

C. difficile - The Main Offender

• Pathogen: Gram-positive, spore-forming, obligate anaerobe rod.
• Pathogenesis: Antibiotic use (esp. clindamycin, cephalosporins, fluoroquinolones) disrupts normal colonic flora, allowing C. difficile overgrowth and toxin production.
  • Toxin A (Enterotoxin): Binds to the brush border, causing inflammation, fluid secretion, and watery diarrhea.
  • Toxin B (Cytotoxin): More potent; causes cytoskeletal disruption, leading to cell death and the formation of characteristic pseudomembranes (yellow-white plaques of fibrin, inflammatory cells, and necrotic debris).
• Complications: Pseudomembranous colitis, toxic megacolon, bowel perforation.

⭐ Diagnosis: Nucleic Acid Amplification Tests (NAATs) are the preferred method for detecting C. difficile toxin genes in stool samples due to their high sensitivity and specificity.

Diagnosis & Management - The Counter-Attack

• Diagnosis:

  • Primary: Stool Nucleic Acid Amplification Test (NAAT) for C. difficile toxin genes.
  • Enzyme immunoassay (EIA) for toxins A/B is less sensitive but highly specific.
  • 💡 Avoid repeat testing within 7 days during the same episode.

• Management Algorithm:

• Advanced/Refractory Cases:
  • Fecal Microbiota Transplant (FMT): Restores gut microbial diversity to prevent spore germination.
  • Bezlotoxumab: Monoclonal antibody against Toxin B, used adjunctively.

⭐ For multiple recurrences, Fecal Microbiota Transplant (FMT) shows superior efficacy (>80% cure rate) compared to standard antibiotic tapers by re-establishing a resilient microbiome.

High‑Yield Points - ⚡ Biggest Takeaways

• Broad-spectrum antibiotics disrupt the protective gut microbiota, creating an opportunity for pathogen overgrowth.
• Clostridioides difficile, a spore-forming anaerobe, is the most common cause.
• Toxins A (enterotoxin) and B (cytotoxin) mediate colonic mucosal injury, leading to inflammation and diarrhea.
• The classic presentation is pseudomembranous colitis.
• Diagnosis is confirmed via stool toxin assays or nucleic acid amplification tests (NAAT).
• Treatment mainstays are oral vancomycin or fidaxomicin.
• Fecal microbiota transplantation (FMT) is highly effective for recurrent cases.